MALAT1 and colorectal carcinoma: Serum MALAT1 was significantly upregulated with a median (IQR) fold change of 102.5 (35.24–136.8) (p < 0.0001) and 20.50 (11.44–39.87) (p = 0.0234) in CRC and AP patients, respectively, compared to healthy controls.